Chronic mild restraint stress rats decreased CMKLR1 expression in distinct brain region

Neuroscience Letters

Volumn 524, Issue 1, 2012, Pages 25-29

  Guo, Xiaoyun ^a   Fu, Yingmei ^a   Xu, Yifeng ^a   Weng, Shimin ^a   Liu, Dengtang ^a   Cui, Donghong ^a   Yu, Shunying ^a   Liu, Xiaohua ^a   Jiang, Kaida ^a   Dong, Yi ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Chronic restraint stress; CMKLR1; Depression; Hippocampus; Prefrontal cortex

Indexed keywords

CHEMOKINE LIKE RECEPTOR 1; CHEMOKINE RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; HIPPOCAMPUS; IMMOBILIZATION STRESS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BRAIN; CEREBELLAR CORTEX; HIPPOCAMPUS; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE; RESTRAINT, PHYSICAL; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 84864628532     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.06.075     Document Type: Article

References (38)

1. Albanesi C., Scarponi C., Pallotta S., Daniele R., Bosisio D., Madonna S., Fortugno P., Gonzalvo-Feo S., Franssen J.D., Parmentier M., De Pita O., Girolomoni G., Sozzani S. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. The Journal of Experimental Medicine 2009, 206:249-258.
2. Aoki H., Hisada T., Ishizuka T., Utsugi M., Ono A., Koga Y., Sunaga N., Nakakura T., Okajima F., Dobashi K., Mori M. Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochemical and Biophysical Research Communications 2010, 400:128-133.
3. Arikawa E., Sun Y., Wang J., Zhou Q., Ning B., Dial S.L., Guo L., Yang J. Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study. BMC Genomics 2008, 9:328.
4. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., Yang R., Petasis N.A., Serhan C.N. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. The Journal of Experimental Medicine 2005, 201:713-722.
5. Arita M., Ohira T., Sun Y.P., Elangovan S., Chiang N., Serhan C.N. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. Journal of Immunology 2007, 178:3912-3917.
6. B.T. Baune, E. Smith, S. Reppermund, T. Air, K. Samaras, O. Lux, H. Brodaty, P. Sachdev, J.N. Trollor, Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study, Psychoneuroendocrinology (2012), [Epub ahead of print].
7. Bondue B., Vosters O., de Nadai P., Glineur S., De Henau O., Luangsay S., Van Gool F., Communi D., De Vuyst P., Desmecht D., Parmentier M. ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia. PLoS Pathogens 2011, 7:e1002358.
8. Bondue B., Wittamer V., Parmentier M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Reviews 2011, 22:331-338.
9. Bosch X. Fish consumption and depression. Lancet 1998, 352:71-72.
10. Connor K.M., SanGiovanni J.P., Lofqvist C., Aderman C.M., Chen J., Higuchi A., Hong S., Pravda E.A., Majchrzak S., Carper D., Hellstrom A., Kang J.X., Chew E.Y., Salem N., Serhan C.N., Smith L.E. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nature Medicine 2007, 13:868-873.
11. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., Keck P.E., Marangell L.B., Richardson A.J., Lake J., Stoll A.L. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. The Journal of Clinical Psychiatry 2006, 67:1954-1967.
12. Frodl T.S., Koutsouleris N., Bottlender R., Born C., Jager M., Scupin I., Reiser M., Moller H.J., Meisenzahl E.M. Depression-related variation in brain morphology over 3 years: effects of stress?. Archives of General Psychiatry 2008, 65:1156-1165.
13. Fu Y., Yu S., Guo X., Li X., Li T., Li H., Dong Y. Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice. Biochimica et Biophysica Acta 2012, 1823:826-837.
14. Gantz I., Konda Y., Yang Y.K., Miller D.E., Dierick H.A., Yamada T. Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors. Cytogenetics and Cell Genetics 1996, 74:286-290.
15. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl.):S81-S96.
16. Graham K.L., Zabel B.A., Loghavi S., Zuniga L.A., Ho P.P., Sobel R.A., Butcher E.C. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease. Journal of Immunology 2009, 183:6717-6723.
17. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37:137-162.
18. Hart R., Greaves D.R. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. Journal of Immunology 2010, 185:3728-3739.
19. Irwin M.R., Wang M., Ribeiro D., Cho H.J., Olmstead R., Breen E.C., Martinez-Maza O., Cole S. Sleep loss activates cellular inflammatory signaling. Biological Psychiatry 2008, 64:538-540.
20. Kaarniranta K., Salminen A. NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD). Experimental Gerontology 2009, 44:685-688.
21. Kempton M.J., Salvador Z., Munafo M.R., Geddes J.R., Simmons A., Frangou S., Williams S.C. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Archives of General Psychiatry 2011, 68:675-690.
22. Lin P.Y., Su K.P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. The Journal of Clinical Psychiatry 2007, 68:1056-1061.
23. Luangsay S., Wittamer V., Bondue B., De Henau O., Rouger L., Brait M., Franssen J.D., de Nadai P., Huaux F., Parmentier M. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. Journal of Immunology 2009, 183:6489-6499.
24. Lucassen P.J., Meerlo P., Naylor A.S., van Dam A.M., Dayer A.G., Fuchs E., Oomen C.A., Czeh B. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. European Neuropsychopharmacology 2010, 20:1-17.
25. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinology Letters 2008, 29:287-291.
26. Martins J.G. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. Journal of the American College of Nutrition 2009, 28:525-542.
27. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological psychiatry 2009, 65:732-741.
28. Monje F.J., Cabatic M., Divisch I., Kim E.J., Herkner K.R., Binder B.R., Pollak D.D. Constant darkness induces IL-6-dependent depression-like behavior through the NF-kappaB signaling pathway. Journal of Neuroscience 2011, 31:9075-9083.
29. Peng J., Liu J., Nie B., Li Y., Shan B., Wang G., Li K. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: a voxel-based morphometry study. European Journal of Radiology 2011, 80:395-399.
30. Raison C.L., Dantzer R., Kelley K.W., Lawson M.A., Woolwine B.J., Vogt G., Spivey J.R., Saito K., Miller A.H. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Molecular Psychiatry 2010, 15:393-403.
31. Raison C.L., Miller A.H. Is depression an inflammatory disorder?. Current Psychiatry Reports 2011, 13:467-475.
32. Sahay A., Hen R. Adult hippocampal neurogenesis in depression. Nature Neuroscience 2007, 10:1110-1115.
33. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology 2008, 8:349-361.
34. Weylandt K.H., Chiu C.Y., Gomolka B., Waechter S.F., Wiedenmann B. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins and Other Lipid Mediators 2012, 97(3-4):73-82.
35. Weylandt K.H., Kang J.X. Rethinking lipid mediators. Lancet 2005, 366:618-620.
36. Wolfe A.R., Ogbonna E.M., Lim S., Li Y., Zhang J. Dietary linoleic and oleic fatty acids in relation to severe depressed mood: 10 years follow-up of a national cohort. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:972-977.
37. Xu Z.Z., Zhang L., Liu T., Park J.Y., Berta T., Yang R., Serhan C.N., Ji R.R. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nature Medicine 2010, 16:592-597. 591 p. following 597.
38. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain, Behavior, and Immunity 2001, 15:199-226.